| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/04/2004 | WO2002020762A8 Tnf receptor-like molecules and uses thereof |
| 03/04/2004 | WO2002020748A8 Host cells for packing a recombinant adeno-associated virus (raav), method for the production and use thereof |
| 03/04/2004 | WO2002018430A8 Nucleotide sequences which code for the metr and metz genes |
| 03/04/2004 | WO2002014352A9 Therapeutic compounds for ovarian cancer |
| 03/04/2004 | WO2001057276A9 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human bone marrow |
| 03/04/2004 | WO1995028959A9 MICE MUTANT FOR Fc RECEPTORS AND METHOD OF TREATING AUTOIMMUNE DISEASE |
| 03/04/2004 | US20040045055 Gene for a Dof transcription factor capable of altering the size and stature of a plant |
| 03/04/2004 | US20040045053 Comprises expression vector coding tissue specific regulatory sequences and polypeptides which inrease crop yields, improve nutritional value of pollen, confer herbicide resistance and controlling fertility in plants |
| 03/04/2004 | US20040045052 Maize Rar1 polynucleotides and methods of use |
| 03/04/2004 | US20040045049 Trangenic heat, freeze, drought and disease resistant plants |
| 03/04/2004 | US20040045046 Transgenic mammals expressing polyglutamine |
| 03/04/2004 | US20040045044 Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same |
| 03/04/2004 | US20040045042 Controlling oocytes, blocking fertility; prevention reproduction |
| 03/04/2004 | US20040045041 Means for the identification compounds capable of inhibiting karap-transduced signals |
| 03/04/2004 | US20040044193 C. albicans tec1 gene (catec1) and the coded tecip protein |
| 03/04/2004 | US20040044192 Genetic engineered polypeptide; diagnosis of Lyme disease |
| 03/04/2004 | US20040044191 Comprises nucleotide sequences coding signal sequence polypeptides for diagnosis, prevention and treatment of cell proliferative, cardiovascular and infectious disorders |
| 03/04/2004 | US20040044188 Identifying peptide mimetic for treatment and prevention of tumors and autoimune diseases |
| 03/04/2004 | US20040044186 Comprises natural killer cell stimulatory factor protein (NKSF) inducing interferons and treating tumors, viral infection and blood disorders |
| 03/04/2004 | US20040044185 Comprises transmembrane protein for use in liposome-based drug and nucleotide delivery systems; gene therapy |
| 03/04/2004 | US20040044184 Comprises cytoskeletal protein for diagnosis, prevention and treatment of cell proliferative, viral and neurodegenerative diseases |
| 03/04/2004 | US20040044183 Peptide inhibitors of HIV entry |
| 03/04/2004 | US20040044182 Genetically engineered human leukocyte antigen-g polypeptide (HLA-G) for altering immunological response during organ transplantation and gestations involving genetically different fetuses |
| 03/04/2004 | US20040044181 Novel nucleic acids and polypeptides |
| 03/04/2004 | US20040044180 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/04/2004 | US20040044179 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/04/2004 | US20040044177 Somatostatin analogue as peptide and chelating group covalently linked to N-terminal free amino group of peptide, wherein analogue carries 1-naphthylalanine or 3-benzothienylalanine residue in 3-position; diagnosis |
| 03/04/2004 | US20040043937 Antiinflammatory agents; osteoporosis; thrombosis; grafting of organs |
| 03/04/2004 | US20040043935 Synthetic immunogenic but non amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits |
| 03/04/2004 | US20040043934 Synthetic peptides that inhibit leukocyte superoxide anion production and/or attract leukocytes |
| 03/04/2004 | US20040043933 Mixture with pH moderator, antioxidant and Group 2a salt; anticoagulant |
| 03/04/2004 | US20040043932 Leptin-related peptides |
| 03/04/2004 | US20040043931 Stimulation, expansion of lymphocytes; polynucleotides; genetic engineering |
| 03/04/2004 | US20040043930 Novel proteins and nucleic acids encoding same |
| 03/04/2004 | US20040043929 Novel proteins and nucleic acids encoding same |
| 03/04/2004 | US20040043928 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 03/04/2004 | US20040043927 Wound healing agents; anticancer agents; cardiovascular disorders |
| 03/04/2004 | US20040043926 Comprises polypeptides for diagnosing, treating and preventing cardiomyopathy, atherosclerosis and cancer |
| 03/04/2004 | US20040043924 Uses of keratinocyte growth factor-2 |
| 03/04/2004 | US20040043923 Detection, calibration binding of ligand to nucleic acids |
| 03/04/2004 | US20040043922 Treatment of case-ready food products with immobilized lactoferrin (Im-LF) and the products so produced |
| 03/04/2004 | US20040043921 Substances and their uses |
| 03/04/2004 | US20040043491 Penicillin production using transgenic merodiploid strains |
| 03/04/2004 | US20040043490 Cells to be used in producing virus vector, process for producing the same, and process for producing virus vector with the use of the cells |
| 03/04/2004 | US20040043489 Gene delivery vectors provided with a tissue tropism for dendritic cells and methods of use |
| 03/04/2004 | US20040043488 Adeno-associated viral gene-transfer vector system |
| 03/04/2004 | US20040043485 Transposable elements in rice and methods of use |
| 03/04/2004 | US20040043471 Production of chimeric human papillomavirus |
| 03/04/2004 | US20040043467 Supracolonic aerodigestive neoplasm detection |
| 03/04/2004 | US20040043464 Comprises nucleotide sequences coding oligosaccharide biosynthetic enzymes for use as tools in genetic engineering and detection of neisseria infections |
| 03/04/2004 | US20040043463 Comprises inhibitory fusion protein topical for treating aberration affecting hair pigmentation, skin pigmentation and/or skin conditioning |
| 03/04/2004 | US20040043457 Bifunctional fusion proteins with glucocerebrosidase activity |
| 03/04/2004 | US20040043456 Novel compounds |
| 03/04/2004 | US20040043454 Growth arrest homeobox gene |
| 03/04/2004 | US20040043452 Comprises embryogenesis associated proteins (EMBRY) for diagnosis, treatment and prevention of reproductive, autoimmune/inflammatory and placental disorders |
| 03/04/2004 | US20040043451 Production process of surfactin |
| 03/04/2004 | US20040043450 Bioactive peptide for cell adhesion |
| 03/04/2004 | US20040043448 Nucleotide sequences |
| 03/04/2004 | US20040043446 Cell-free in vitro method of remodeling a peptide molecule, including the addition or deletion of one or more glycosyl groups to a peptide, and/or the addition of a modifying group to a peptide; treatment of Fabry disease |
| 03/04/2004 | US20040043438 Allergen mutants |
| 03/04/2004 | US20040043437 Inducible cancer model to study the molecular basis of host tumor cell interactions in vivo |
| 03/04/2004 | US20040043435 Method for the detection of apoptosis by determining apoptosis-specific markers released into an extracellular medium through cellular release mechanisms |
| 03/04/2004 | US20040043432 Comprises soluble chimeric derivative of decay accelerating factor (DAF) for treating inflammatory and immune disorders |
| 03/04/2004 | US20040043426 Using "tethering" where potential ligands are covalently bonded or "tethered" to a target and subsequently identified |
| 03/04/2004 | US20040043425 Screening, detecting and/or prognosing respiratory system disorders; bronchodilator agents |
| 03/04/2004 | US20040043424 Immunoglobulin superfamily proteins |
| 03/04/2004 | US20040043412 Extracellular novel RAGE binding protein (EN-RAGE) and uses thereof |
| 03/04/2004 | US20040043408 Alzheimer's disease secretase, APP substrates therefor, and uses therefor |
| 03/04/2004 | US20040043406 Reagents and methods useful for detecting diseases of the gastrointestinal tract |
| 03/04/2004 | US20040043402 Interferon-alpha induced gene |
| 03/04/2004 | US20040043401 Nucleic acids encoding chimeric T cell receptors (TCRs), methods of using them to facilitate a T cell response to a selected target |
| 03/04/2004 | US20040043397 Identification and isolation of novel DNA and the recombinant production of polypeptides having sequence similarity to interleukin-17 and interleukin-17 receptor protein |
| 03/04/2004 | US20040043395 Use of these sequences in the diagnosis, treatment, and prevention of cell proliferative, autoimmune/inflammatory, neurological, gastrointestinal, reproductive, and developmental disorders |
| 03/04/2004 | US20040043394 Arylhydrocarbon receptor (AhR) |
| 03/04/2004 | US20040043393 AXOR35, a G-protein coupled receptor |
| 03/04/2004 | US20040043391 Leptospira vaccine antigens for the prevention of Leptospirosis |
| 03/04/2004 | US20040043382 Novel proteins and nucleic acids encoding same |
| 03/04/2004 | US20040043381 Multiple sclerosis associated retrovirus (MSRV) -1 ; long terminal repeat sequences (LTR) |
| 03/04/2004 | US20040043074 Oxidized collagen formulations for use with non-compatible pharmaceutical agents |
| 03/04/2004 | US20040043063 In situ transfection; gene therapy; protein in liposome capsules |
| 03/04/2004 | US20040043037 Staphylococcus aureus polynucleotides and sequences |
| 03/04/2004 | US20040043036 Binding to protein; adjustment concentration of calcium compound in cells |
| 03/04/2004 | US20040043035 Recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine |
| 03/04/2004 | US20040043034 Collectins as adjuvants |
| 03/04/2004 | US20040043033 Method and vaccine for the prevention of AIDS |
| 03/04/2004 | US20040043031 Methods for promoting growth of bone, ligament, and cartilage |
| 03/04/2004 | US20040043029 Novel antibodies reactive with human carcinomas |
| 03/04/2004 | US20040043028 Methods and compositions for enhanced protein expression and/or growth of cultured cells using co-transcription of a Bcl2 encoding nucleic acid |
| 03/04/2004 | US20040043027 Antiproliferative agents |
| 03/04/2004 | US20040043025 Growth differentiation factor-12 |
| 03/04/2004 | US20040043024 Genetic engineering; isolation nucleic acids binded to heparin |
| 03/04/2004 | US20040043023 Therapy, diagnosis of leukemia; detection of cancer lymphocytes in human |
| 03/04/2004 | US20040043022 Immunology diseases; rheumatic disorders; anticancer agents; antiinflammatory agents; multiple sclerosis; lymphocyte stimulants |
| 03/04/2004 | US20040043017 Prothrombin activating protein |
| 03/04/2004 | US20040043004 Anticancer agents; gastrointestinal disorders |
| 03/04/2004 | US20040043000 Method of modulating fertility in animals |
| 03/04/2004 | US20040042961 Using mutant green fluorescent protein |
| 03/04/2004 | DE10238433A1 Verfahren zur Bestimmung des allelischen Zustandes des 5'-Ende des alpha-S1-Kaseingenes A method for determining the allelic state of the 5 'end of the alpha-S1-Kaseingenes |
| 03/04/2004 | DE10233082A1 Fluoreszierendes Protein Fluorescent protein |
| 03/04/2004 | DE10141464A1 New nucleic acid representing a polymorphism in the 22444 gene, useful for diagnosis and treatment of neuropsychiatric diseases and in drug screening |